Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.68
+0.02000.43%
Post-market: 4.680.00000.00%19:38 EDT
Volume:475.31K
Turnover:2.24M
Market Cap:146.44M
PE:-1.13
High:4.81
Open:4.71
Low:4.67
Close:4.66
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:0.74
T/O Rate:2.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.67
PE(LYR):-1.64

Loading ...

Press Release: ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

Dow Jones
·
Aug 13

Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Aug 13

Lensar Q2 Revenue Rises 18%, Returns to Profit

Reuters
·
Aug 13

Canaccord Genuity Initiates Kazia Therapeutics at Buy With $29 Price Target

MT Newswires Live
·
Aug 13

Pelthos Therapeutics Q2 EPS $(6.62) Misses $(3.05) Estimate, Sales $15.603M Beat $15.273M Estimate

Benzinga Earnings
·
Aug 13

Lenz Therapeutics, Inc. : Bofa Global Research Cuts to Neutral from Buy; Cuts Price Objective to $7 from $31

THOMSON REUTERS
·
Aug 13

Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
Aug 13

Lenz Therapeutics, Inc. : Citigroup Cuts Target Price to $10 from $20

THOMSON REUTERS
·
Aug 13

Outlook Therapeutics Prices $55 Million Securities Offering; Shares Down Pre-Bell

MT Newswires Live
·
Aug 13

CRISM Therapeutics Clears Key Step to Begin Phase II Glioblastoma Trial

TIPRANKS
·
Aug 13

Mineralys Therapeutics Confronts Heightened Refinancing and Liquidity Risks as 2031 Debt Maturity Looms

TIPRANKS
·
Aug 13

Relmada Therapeutics Earnings Call Highlights NDV-01 Path

TIPRANKS
·
Aug 13

Silence Therapeutics Announces Major ADS Public Offering

TIPRANKS
·
Aug 13

Allogene Therapeutics Q2 Loss Narrows

MT Newswires Live
·
Aug 13

Cardiol Therapeutics Reports Second-Quarter 2026 Interim Results

TIPRANKS
·
Aug 13

Turn Therapeutics Q2 EPS $(0.20) Misses $(0.02) Estimate

Benzinga Earnings
·
Aug 13

Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks

TIPRANKS
·
Aug 13

Sangamo Therapeutics Reports Post-Bankruptcy Operating Developments

TIPRANKS
·
Aug 13

Press Release: Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 13

STAAR Surgical Q2 Net Sales Jump on China Sales Growth

Reuters
·
Aug 13